Shilpa - Case Study

Case Study: Accelerating Biotech CDMO Innovation with Factorian 

The Challenge: Data Silos in a Multi-Sponsor Environment 
As a leading Biotech CDMO, the customer faced a monumental data challenge. Spanning across R&D and GMP manufacturing, crucial process data was trapped in isolated lab instruments and proprietary control systems. With no centralized way to capture or archive data from 150+ machines, this “data blackout” hindered both internal process development and external transparency: 

• Fragmented R&D Data: Valuable run data from small R&D reactors, purification systems, and lab instruments was captured manually, slowing down process development cycles. 

• GMP Visibility Gaps: Lack of real-time visibility into Bioreactors, Chromatography systems, and Filling lines in GMP suites made it difficult to respond to process drifts instantly. 

• Sponsor Reporting Bottlenecks: Providing updates to sponsors required manual data extraction and reconciliation, delaying critical decision-making for contracted products. 

The Solution: Unified Data Gateway & Sponsor Collaboration 
The CDMO deployed the Factorian to bridge the gap between complex hardware and modern analytics, creating a single source of truth across the entire product lifecycle: 

1. Massive Scale Connectivity: Seamlessly integrated 150+ machines, from benchtop R&D equipment to large-scale GMP Bioreactors and Filling lines. 
2. End-to-End Archiving: Established a robust pipeline to capture high-fidelity data from process development through to commercial manufacturing. 
3. Real-Time Sponsor Portals: Leveraged Factorian’s secure architecture to share live process data directly with sponsors, providing unprecedented transparency into their specific product runs. 

The Impact 

• Faster Process Development: Clean, contextualized R&D data streams allowed the Process Science team to develop processes faster, significantly shortening process development and scale-up timelines. 

• Enhanced Sponsor Trust: By offering real-time data sharing, the CDMO differentiated itself as a “transparent partner,” allowing sponsors to monitor their products as if they were on the shop floor. 

• GMP Operational Excellence: Live monitoring of 2,000+ tags across the manufacturing suites identified deviations before they impacted yield, ensuring higher batch success rates. 

Infrastructure Overview: Factorian’s Footprint 

 Strategic Outcome 

By implementing Factorian, the Biotech CDMO moved from manual data silos to a live real-time, sponsor-centric environment. This digital transformation didn’t just optimize internal efficiency, it created a competitive advantage by delivering faster development cycles and radical transparency to their global sponsors.